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Exposing murine macrophages infected with the protozoan parasite Toxoplasma
gondii to micromolar concentrations of some cationic electron carriers (dyes),
resulted in complete killing of the intracellular parasites at concentrations at which
these compounds did not seem toxic for the macrophages. The 50% inhibitory
concentrations (with 95% confidence limits) were calculated as 0-26 (018-0-37),
1-35 (1-2-25), 0-45 (013-1-50), and 1-52 (0-91-2-53) tm for crystal violet, phenazine
methosulphate, methylene blue and brilliant cresyl blue, respectively. The effects of
these electron carriers did not appear to be the result of an enhancement of the
natural antitoxoplasmic activity of the macrophages. None of the tested compounds
was active against extracellular Tox. gondii as measured by ability to rcinfect murine
macrophages; thus, these dyes seem to act primarily on actively metabolizing,
intracellular, Tox. gondii. Our data also suggest that the killing effect of the electron
carriers was not related to the generation of reactive oxygen intermediates as judged
by the inability of scavengers of these intermediates to block the activity against
intracellular Tox. gondii. Further studies with related redox compounds would have
an interesting chemotherapeutic perspective for treating toxoplasma infections.
Introduction
Toxoplasma gondii is a ubiquitous protozoan parasite which can cause disease in man.
No satisfactory cidal therapy is available for treating life-threatening toxoplasma
infections which can occur among patients with the Acquired Immune Deficiency
Syndrome (AIDS).
It seems to be well established that components of the cellular immune response
(mononuclear phagocytic system) are the main effectors of defence against this obligate
intracellular parasite. Activated macrophages are able to kill Tox. gondii in vitro, and
this killing seems to be associated with the ability of the macrophages to release
reactive oxygen intermediates (ROI) such as superoxide anion, hydrogen peroxide and
hydroxyl radical (Nathan et al., 1983; Murray, Spitalny & Nathan, 1985). Studies have
shown that cationic electron carriers, which are thought to undergo redox-cycling and
generating superoxide anion and hydrogen peroxide (Hassan & Fridovich, 1979), were
able to inhibit intracellular Trypanosoma cruzi and Leishmania spp. (Rabinovitch
et al., 1982; Alves & Rabinovitch, 1983; Mauel, Schnyder & Baggjolini, 1984). One of
these electron carriers, the triarylmethane dye crystal violet (gentian violet), was shown
to be active against extracellular Tryp. cruzi in vitro (Nussenzweig et al., 1953). Since
then, this dye has been used by blood banks in Latin-American endemic countries in
an attempt to reduce the transmission of Chagas' disease. The mechanism of action of
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these compounds, however, has not been elucidated. Here, the in-vitro activity of
cationic electron carriers against extracellular and intracellular tachyzoites of Tox.
gondii was investigated.
Materials and methods
Animals
Female Swiss-Webster mice (Madorin, FiiUinsdorf, Switzerland), weighing 23 to 25 g
each, were used in all experiments.
Macrophages
Animals were killed by CO2 asphyxiation, their resident peritoneal macrophages were
harvested from their peritoneal cavities as described previously (Chang & Pechere,
1988), and the concentration of mononuclear cells was adjusted to 2x 106/ml with
medium 199 (M199) supplemented with 10% fetal calf serum (FCS) (pH 7-2). Each
well of a 96-well tray (Costar, Cambridge, Massachussetts), or each chamber of four-
chamber Lab-Tek slides (Lab-Tek Div., Miles Laboratories Inc., Naperville, Illinois),
was seeded with 2 x 103 and 2 x 106 cells, respectively. They were incubated for 2-3 h
at 37°C in a 5% CO2-95% air humid atmosphere. The nonadherent cells were
discarded by washing twice with prewarmed Hanks' balanced salt solution (HBSS).
Electron carriers
The following electron carriers were obtained from Fluka AG, Buchs, Switzerland:
brilliant cresyl blue (mol. wt, 385-96), crystal violet (mol. wt, 407-99), methylene blue
(mol. wt, 319-86) and phenazine methosulfate (mol. wt, 306-34). They were dissolved in
culture medium and sterilized by nitration immediately before use.
Scavengers of oxygen intermediates
Scavengers of oxygen intermediates (Catterall, Sharma & Remington, 1986) were
obtained from Sigma GmbH, Deisenhofen, West Germany, and used at the
concentrations shown. Superoxide dismutase, 3000 U/mg (2-5 mg/ml) was used for
superoxide anion; catalase from bovine liver recrystallized twice (2-5 mg/ml) for
hydrogen peroxide; and histidinc (10 mM) and diazabicyclooctane (1 ITLM) for singlet
oxygen radicals. The scavengers of hydroxyl radicals were benzoic acid (10 mM),
mannitol (50 mM) and tetramethylurea (25 mM). These scavengers were added to the
monolayers immediately after the 1 h challenge with Tox. gondii and 30 min before the
addition of the cationic electron carriers. All these experiments were performed over a
24-h period of incubation.
Tox. gondii infection and microbicidal assays
Cell cultures were challenged for 1 h with 2 x 10s (96-well trays) or 2 x 106 (Lab-Tek
slides) RH strain Tox. gondii tachyzoites. After uningested parasites had been removed
by washing, standard medium containing reagents was added and the monolayers were
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pulsed with 2-5 /iCi of [5-6-3H]uracil (specific activity 49 Ci/mmol; Amersham pic,
Buckinghamshire, England). After a 24-h period of incubation the radioactivity was
counted in the acid-precipitable material by filtration procedure (Chang & Pechere,
1988). The inhibition of the intracellular Tox. gondii growth rate was thus assessed by
using [3H]uracil, a precursor which is incorporated by Tox. gondii, but not the host
cells (Chang & Pechere, 1988). In addition, the outcome of intracellular infection was
assessed by microscopically counting the number of infected cells and the number of
intracellular parasites per 100 cells in Giemsa-stained preparations. An
antitoxoplasmic effect was indicated by a decrease in the parameters considered at
24 h.
Effects of electron carriers on extracellular toxoplasmas
Fresh suspensions of Tox. gondii (3-6 x 106 tachyzoites/ml) were incubated in 5%
CO2-95% air at 37°C with the electron carriers for 30min at the desired
concentrations. The suspensions were centrifuged at 50 g for lOmin, washed with
phosphate-buffered saline (pH 7-2), centrifuged again and resuspended in Ml99 with
3% FCS. They were used to challenge macrophage monolayers for [3H]uracil
experiments and for Giemsa-stained preparations.
Effect of electron carriers on antitoxoplasmic activity of resident macrophages
Mouse macrophage monolayers were exposed for 24 h to the electron carriers at the
desired concentrations. At the end of the incubation period, the monolayers were
washed three times with prewarmed HBSS and challenged with freshly harvested Tox.
gondii for 1 h. Assessment of Tox. gondii inhibition was made after a 24-h incubation
period in medium without the electron carriers.
Assessment of toxicity on macrophages
Adherent macrophage monolayer cells were incubated for 24 h with different
concentrations of the electron carriers and their viability was assessed as described
previously (Chang & Pechere, 1988), by the trypan blue dye exclusion test. In addition,
macrophage monolayers were examined in Giemsa-stained preparations, after 24 h
incubation, for the number of cells per high power field and assessed for their
morphological characteristics-.
Statistics
Data are reported as the mean ± standard error of the mean (SEM). The 50%
inhibitory concentrations (IC30), the 95% confidence limits, and the IC90 w e r e
calculated by probit analysis following the method of Litchfield & Wilcoxon (1949).
differences between values were analyzed by the Student's r-test. A P value <0-05 was
considered significant.
Results
Activity of electron carriers on intracellular toxoplasmas
Infected murine peritoneal macrophages were exposed to increasing amounts of the
electron carriers in concentrations from 0001 to 35/ZM, and the growth rate of
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Table I. Activity of cationic electron carriers against intracellular Tox.
gondii as assessed by [3H]uracil assay
Treatment of infected
macrophages
Crystal violet
Phenazine
methosulphate
Methylene blue
Brilliant cresyl blue
50% Inhibitory
concentration (IC50)
(jot) (95% fiducial
range)
0-26 (018-0-37)
1-35 (1-00-2-25)
0-45 (0 13-1-50)
1-52 (0-91-2-53)
90% Inhibitory
concentration (IC,0)
0-43
2-38
2-38
3-24
intracellular Tox. gondii was assessed by measuring the uptake of [3H]uracil over a
period of 24 h. Micromolar concentrations of all electron carriers tested were able to
restrict the intracellular multiplication of the parasite. This allowed calculation of their
ICS0 and IC90 as shown in Table I. Table n summarizes the results of experiments
performed with microscopically assessed preparations. All electron carriers at their
respective IC90, according to the [3H]uracil incorporation studies, significantly reduced
the number of infected cells and the number of toxoplasmas per 100 cells, and at
higher concentrations allowed complete eradication of the parasites from the
macrophages. These effects were seen at concentrations which were not toxic for the
macrophages according to the trypan blue dye exclusion test and morphological
criteria. By raising the concentrations, toxic effects on the cells however, appeared with
increased concentrations of crystal violet, phenazine methosulphate and methylene blue
(Table II).
Effect of electron carriers on extracellular toxoplasmas
The electron carriers did not alter the viability of extracellular Tox. gondii, assessed by
their ability to reinfect macrophage cultures (Table III).
Table II. Activity of cationic electron carriers against intracellular Tox. gondii as assessed by
microscopy
Treatment of infected
macrophages with
electron carriers (jot)
Medium only (control)
Crystal violet
Phenazine
methosulphate
Methylene blue
Brilliant cresyl blue
(0-43)
(2-38)
(5)
(2-38)
(15)
(3.24)
(31)
%of
infected
cells
56±4
0*
8±1»
0i
7±1»
0*
5±1»
0*
Number of
toxoplasmas
per 100 cells
717±8
0*
16±T
0*
11 ± 1 '
0*
11±1'
0*
Minimal concentration
for toxicity to macrophage
monolayers (/u*)"
0-55
7
30
No toxicity up to 35
Results are the mean ±SEM of three experiment!.
'Assessed by trypan blue dye exclusion and morphological criteria.
*P<0-01, compared to control; 'P< 0-001, compared to control; 'P < 0-0001, compared to control;
'P < 0-00001, compared to control.
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Tabte m . Effect of cationic electron carriers on extracellular Tox. gondii as assessed by
subculture
Pretreatment with
electron carriers (JM)
Extracellular Tox. gondii
None
Crystal violet
Phenazine methosulpbate
Methylene blue
Brilliant cresyl blue
(0-43)
(2-38)
(2-38)
(3.24)
% of infected
cells
49±1
48±2
53±2
51±1
48±1
Number of toxoplasmas
per 100 macrophages
629±6
611±7
665±9
640±5
614±8
Incorporation of
pHJuradl*
100
94±8-3
98±91
99 ±6-8
96 ±7-5
Results are the mean ±SEM of three experiments.
"Expressed as percentage of intracellular inhibition; (100-cpm in test/cpm in control) x 100.
Effect on anti-toxoplasma activity of resident macrophages
In order to test whether or not these compounds produced some degree of macrophage
activation, we incubated resident macrophage monolayers with the different electron
carriers for 24 h, and challenged them with Tox. gondii. None of the tested electron
carriers was able to enhance the antitoxoplasmic activity of the resident mouse
macrophages (Table IV).
Effect of scavengers of oxygen intermediates
We further investigated the effect of scavengers of oxygen intermediates on the activity
of the cationic electron carriers at their corresponding IC90. The scavengers of ROI
did not block the ability of electron carriers to kill intracellular Tox. gondii at the
concentrations tested (Table V).
Discussion
These studies showed that electron carriers were toxoplasmacidal in vitro at
micromolar concentrations; the parasites were completely eradicated from the
macrophages at some of the concentrations tested. The combination of pyrimethamine
Table IV. Effect of cationic electron carriers on antitoxoplasmic activity of macrophages
Pretrcatment with
electron carriers (jot)
Resident mouse macrophages
None
Crystal violet
Phenazine methosulphate
Methylene blue
Brilliant cresyl blue
(0-43)
• (2-38)
(238)
(3-24)
% of infected
cells
47±1
45±2
51±2
47±3
50±2
Number of toxoplasmas
per 100 macrophages
597 ±8
591 ±7
628±9
594±6
583 ±12
Incorporation of
['HJuracU*
100
95 ±3-8
93 ±7-6
94±7-8
97 ±5-3
Results are the mean ±SEM of three experiments.
•Expressed as percentage of intracellular inhibition: (100-cpm in test/cpm in control) x 100.
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Table V. Effects of scavengers of oxygen intermediates on the activity of cationic electron
carriers against intracellular Tox. goruUf
Treatment of infected
macrophages*
Crystal Phenazine Methylene Brilliant
None violet methosulphate blue cresyl blue
Medium only 100
Catalase (2-5 mg/ml) 102±5-7
Superoxide dismutase (2-5 mg/ml) 96±6-9
Histidine (10 HIM) 97 ±7-9
Diazabicyclooctane (mM) 94 ±9-7
Mannitol (50 mu) 99 ±5-2
Benzoic acid (25 mM) 97 ±6-8
Tetramethylurea (25 mM) 98 ± 5-3
8-5 ±1-3
4-9 ±0-7
4-9 ±0-8
100±l-3
6-8 ±1-9
10-7±2-l
5-7 ±0-9
5-2+1-2
16-8±2-3
21-3±2-7
24-8 ± 3 0
21-9±2-4
18-1 ±2-6
13-0±3-5
ll-2±l-6
130±l-2
15-5±3-8
23-5±l-O
17-3±3-2
16-8 ±2-4
19-7 ±3-5
19-7±3-6
18-3±2-l
19-4 ±1-8
16-9±3-5
19 4 ± 1 0
25-5±31
140 ±2-2
13-7±0-5
17-5±0-8
17-8±l-0
13-9 + 0-3
"Measured by [3H]uracil assay, and expressed as percentage of intracelhilar inhibition as stated in
Table III and IV.
*The electron carriers were added at their respective 90% inhibitory concentrations as shown in Table I.
and sulphadiazine, investigated in a similar system, was also active against Tox. goiuiii
at the micromolar level, but exerted less killing effect (Chang & Pechere, 1988).
The electron carriers could have stimulated the macrophages to kill the parasites or
could have acted directly on the intracellular parasites. Regarding a macrophage-
mediated mechanism, some studies have suggested that the intracellular killing of
leishmania by electron carriers, excepting crystal violet, correlated with the stimulation
of the hexose monophosphate shunt, and with the generation of ROI (Maud et al.,
1984). Here, stimulation of the release of ROI was unlikely since the antitoxoplasma
activity of the electron carriers was not altered by the scavengers of ROI. Pretreatment
of macrophages with electron carriers did not enhance the antitoxoplasmic activity of
these cells, an observation which also tips the balance in favour of a direct antiparasitic
effect. Since the electron carriers were not active against extracellular Tox. gondii, but
only against actively growing intracellular parasites, an interference with the parasites'
metabolism by the electron carriers is suggested. Some arguments for direct damage to
the intracellular parasites can be found elsewhere. Phenazine methosulphate has been
found to accumulate in the parasitophorous vacuoles of macrophages infected with
leishmania (Rabinovitch et al., 1982). A mechanism for a direct anti-Tryp. cruzi effect
has been proposed for crystal violet, consisting in a photodynamic action apparently
mediated by the formation of carbon-centred free radicals in the parasites themselves
(Docampo et al., 1983). An alternative mechanism could be direct oxidative damage to
the parasites. In this view, a correlation of between toxoplasmacidal action and the
redox potential of the electron carriers would have been expected. This was not the
case, here, nor with other intracellular parasites also susceptible to the electron carriers
(Rabinovitch et al., 1982; Alves & Rabinovitch, 1983; Mauel et al., 1984). However,
such correlation is likely to be obscured by other structural requirements for drug
permeation (Rabinovitch et al., 1983; Mauel et al., 1984).
In conclusion, we have shown that these electron carriers are toxoplasmacidal, but
the mechanisms of their impressive activity remain unclear. Further investigation is
warranted with these and related compounds because of their interesting
chemotherapeutic perspective.
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